Developing novel genetically modified vaccines to protect against common seasonal influenza and emergent pandemic influenza. Formed to commercialize patented vaccine and virus technologies developed at the Mount Sinai School of Medicine, Vivaldi’s program represents a breakthrough approach to flu vaccine development and production and a major advance over flu vaccines available today.
Vivaldi Biosciences
